RESLIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 09:35:52 GMT 2025` Edited by `admin` on `Wed Apr 02 09:35:52 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG4
Sequence Origin	HUMANIZED RAT
Sequence Type	UNKNOWN
Record UNII	35A26E427H
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 ?4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer

Preferred Name

English

RESLIZUMAB

Official Name

English

MAB HUMAN (IGG4) ANTI P05113 (IL5_HUMAN) (SCH55700)

Common Name

English

reslizumab [INN]

Common Name

English

RESLIZUMAB [MI]

Common Name

English

CEP-38072

Code

English

DCP-835

Code

English

SCH55700

Code

English

RESLIZUMAB [USAN]

Common Name

English

CINQAIR

Brand Name

English

Reslizumab [WHO-DD]

Common Name

English

RESLIZUMAB [PURPLE BOOK CDER]

Common Name

English

SCH-55700

Code

English

DCP 835

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

328510

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

FDA ORPHAN DRUG

237507

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

NDF-RT

N0000191872

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

WHO-ATC

R03DX08

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

NCI_THESAURUS

C20401

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

NCI_THESAURUS

C29712

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

Code System Code Type Description

NCI_THESAURUS

C152197

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

USAN

LL-65

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

DRUG CENTRAL

5093

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

DRUG BANK

DB06602

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

INN

8106

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

RXCUI

1746889

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

EVMPD

SUB96120

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

FDA UNII

35A26E427H

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

DAILYMED

35A26E427H

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

SMS_ID

100000141689

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

MERCK INDEX

m9543

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

Merck Index

CAS

241473-69-8

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

LACTMED

Reslizumab

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

ChEMBL

CHEMBL2107884

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

NDF-RT

N0000191871

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

Interleukin-5 Antagonists [MoA]

WIKIPEDIA

RESLIZUMAB

Created by admin on Wed Apr 02 09:35:52 GMT 2025 , Edited by admin on Wed Apr 02 09:35:52 GMT 2025

PRIMARY

From	To
1_22	1_95
2_22	2_95
2_130	4_214
2_143	2_199
2_257	2_317
1_130	3_214
2_363	2_421
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_143	1_199
1_222	2_222
1_225	2_225
1_257	1_317
1_363	1_421

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_293
N	2_293

Related Record Type Details


					35A26E427H

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID REMOVAL	[1_443] [2_443]	C-TERMINUS	K		LYSINE	K3Z4F929H6

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:ESTIMATE	CHEMICAL
Molecular Formula	CHEMICAL